Geneyx Genomex

AI-based Genetic Data Analysis Platform

Health Tech & Life Sciences
Active
Seed Herzliya, Israel Founded 2018
Last updated 2026-06-18
Total raised
$14.0M
Last: Grant 2023-10
Stage
Seed
Founded
2018
Headcount
31
HQ
Herzliya, Israel
Sector
Health Tech & Life Sciences

About

Geneyx is driven by the belief that comprehensive genomic insights are essential for every patient’s care. Its mission is to transform the integration of genomics into healthcare and pharmaceutical research with a sophisticated data analysis platform. Serving a wide range of clients, including hospitals, genetics labs, and life-science companies, Geneyx offers unmatched precision in genetic analysis and research.

Geneyx Analysis is a comprehensive platform for secondary and tertiary analysis of germline and somatic sequencing data interpretation. This comprehensive tool tailors to all aspects of in-house bioinformatic pipelines but alleviates the complexities of staying current with current genomic information. Its team strives to provide a resource that significantly improves diagnostic yields and turnaround times, and its mission is to provide a platform that achieves a world without undiagnosed diseases.

Funding history · 8 rounds · $14.0M total

2023-10
Grant $150K
2023-07
Grant $850K
2022-07
$3.0M
2021-03
Grant Undisclosed
2019-06
Grant Undisclosed
2019-03
Grant Undisclosed
2018-09
Undisclosed

Q&A

What is Geneyx Genomex's primary focus?
Geneyx Genomex specializes in an AI-based Genetic Data Analysis Platform, aiming to integrate comprehensive genomic insights into healthcare and pharmaceutical research.
When was Geneyx Genomex founded?
Geneyx Genomex was founded in July 2018.
How many employees does Geneyx Genomex have?
Geneyx Genomex has 11-50 employees.
What is the total amount of funding Geneyx Genomex has raised to date?
Geneyx Genomex has raised a total of $14,000,000 USD.
When was Geneyx Genomex's most recent funding round and what was the amount?
Geneyx Genomex's most recent funding was a Grant round in October 2023, raising $150,000 USD.
Which investors participated in Geneyx Genomex's $10,000,000 funding round in November 2021?
The $10,000,000 funding round in November 2021 was led by Accenture Ventures, with participation from Capri Ventures.
Who are the co-founders of Geneyx Genomex?
The co-founders of Geneyx Genomex are David Yizhar (Co-founder & CEO), Raviv Itzhaky (Co-founder & CMO), and Ofer Barnea (Co-founder & Scientific Advisor).
What is the current stage of Geneyx Genomex according to startupim data?
Geneyx Genomex is currently in the Seed stage.

Team · 3

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder & CMO
LinkedIn ↗
Founder · Co-founder & Scientific Advisor
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsMedical Decision Support
Technologies
Platforms & InterfacesSoftwareArtificial IntelligenceBiologicalsGenes
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesProvidersLife SciencesPharmaceuticals
Business model
B2B

Highlights

Verified

Tags

clinical-trialshealth-informationpharma-companiesdata-analyticslaboratoriesclinicsprivacy-protectiondigital-healthcaredoctorsgenomicsclinical-datadiagnosticshospitalsbioinformaticsartificial-intelligencedigital-therapeuticsgenetics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)